Menta Capital’s Apyx Medical APYX Stock Holding History

Menta Capital’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-10,302	Closed	-$65K	–	486
2019 Q1	$65K	Buy	+10,302	New	+$79.7K	0.03%	456

Other funds holding APYX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Menta Capital's APYX Position: Q2 2019 in Review

Menta Capital sold out of Apyx Medical (APYX) in Q2 2019, closing a stake of 10,302 shares — an estimated $65K sold.

Menta Capital first reported a position in APYX in Q1 2019 and held it in 1 quarter. The position peaked at $65K in Q1 2019. 66 funds tracked by Wall St. Rank hold APYX as of Q2 2019.

Menta Capital reported no remaining Apyx Medical position as of Q2 2019 after selling out during the quarter.
Menta Capital sold 10,302 Apyx Medical shares in Q2 2019, an estimated $65K.
Menta Capital first reported a position in Apyx Medical in Q1 2019 and held it in 1 quarter.
Menta Capital's Apyx Medical position peaked at $65K in Q1 2019.
66 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2019.

Based on Menta Capital's 13F filing for Q2 2019, filed 7 Aug 2019.